Evaluation of umbilical cord serum therapy in acute ocular chemical burns

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 1087-1092

  Sharma, Namrata ^a   Goel, Manik ^a   Velpandian, Thirumurthy ^a   Titiyal, Jeewan S ^a   Tandon, Radhika ^a   Vajpayee, Rasik B ^a,b,c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; GLYCEROL; HYDROXYPROPYLMETHYLCELLULOSE; EYE DROPS;

ADULT; ARTICLE; CAUSTIC BURN; CHEMICAL BURN; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA OPACITY; DOUBLE BLIND PROCEDURE; EPITHELIZATION; EYE BURN; EYE PAIN; HUMAN; INJURY SEVERITY; ISCHEMIA; LIMBAL ISCHEMIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SERUM; SYMBLEPHARON; UMBILICAL CORD BLOOD; VISUAL ACUITY; ACUTE DISEASE; AUTOTRANSPLANTATION; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CORNEA; CORNEA DISEASE; CORNEA EPITHELIUM; DRUG EFFECT; FETUS BLOOD; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; WOUND HEALING;

ACUTE DISEASE; ADULT; BURNS, CHEMICAL; CORNEA; CORNEAL DISEASES; DOUBLE-BLIND METHOD; EPITHELIUM, CORNEAL; EYE BURNS; FETAL BLOOD; HUMANS; OPHTHALMIC SOLUTIONS; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; VISUAL ACUITY; WOUND HEALING;

EID: 79953270082     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4170     Document Type: Article

References (30)

1. McCulley JP. Chemical injuries of the eye. In: Leibowitz HM, Waring GO. Corneal Disorders: Clinical Diagnosis and Management. 2nd ed. Philadelphia: W.B. Saunders; 1998:770-790.
2. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27:459-461.
3. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol. 1999;83:390-395.
4. Rocha EM, Pelegrino FS, de Paiva CS, Vigorito AC, de Souza CA. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant. 2000;25:1101-1103.
5. del Castillo JM, del la Casa JM, Sardina RC. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002;21:781-783.
6. Young AL, Cheng AC, Ng HK, et al. The use of autologous serum tears in persistent epithelial defect. Eye. 2004;18:609-614.
7. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111:1115-1120.
8. Vajpayee RB, Mukerji N, Tandon R, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol. 2003;87:1312-1316.
9. Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007;144:86-92.
10. Yoon KC, You IC, Im SK, Jeong TS, Park YG, Choi J. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology. 2007;114:1637-1642.
11. Yoon KC, Jeong IY, Im SK, Park YG, Kim HJ, Choi J. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transplant. 2007;39:231-235.
12. Yoon KC, Im SK, Park YG, Jung YD, Yang SY, Choi J. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea. 2006;25:268-272.
13. Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85:1188-1197.
14. Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimized protocol for the production of autologous serum eye drops. Graefes Arch Clin Exp Ophthalmol. 2005;243:706-714.
15. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. Br J Ophthalmol. 2001;85:1379-1383.
16. Tamhane A, Vajpayee RB, Biswas NR, et al. Evaluation of amniotic membrane transplant as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. Ophthalmology. 2005;112:1963-1969.
17. Mukerji N, Vajpayee RB, Sharma N. Technique of area measurement of epithelial defects. Cornea. 2003;22:549-551.
18. Blanco AA, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol. 1999;83:399-402.
19. Tseng SCG, Prabhasawat P, Barton K, et al. Amniotic membrane transplantations with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116:431-441.
20. Tripathi BJ, Kwait PS, Tripathi RC. Corneal growth factors: a new generation of ophthalmic pharmaceuticals. Cornea. 1990;9:2-99.
21. Singh G, Foster CS. Epidermal growth factor in alkali burned corneal epithelial wound healing. Am J Ophthalmol. 1987 15;103: 802-807.
22. Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulin like growth factor1 (letter). Arch Ophthalmol. 1997;115:926-927.
23. Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived-peptide (FGLM) and insulin like growth factor1 (letter). Lancet. 1998; 351:1783-1784.
24. Tan MH, Bryars J, Moore J. Use of nerve growth to treat congenital neurotrophic corneal ulceration. Cornea. 2006;25:352-355.
25. Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med. 1998;338:1174-1180.
26. Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000; 107:1347-1351.
27. Gordon JF, Johnson P, Musch DC, and the Chiron Vision Fibronectin Study Group. Topical fibronectin ophthalmic solution in the treatment of persistent defects of corneal epithelium. Am J Ophthalmol 1995;119:281-287.
28. Phan TM, Foster CS, Boruchoff SA, et al. Topical fibronectin in the treatment of persistent corneal epithelial defects and trophic ulcers. Am J Ophthalmol. 1987;104:494-501.
29. Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin. 2000;40:113-122.
30. Yoon KC, Heo H, Jeong IY, Park YG. Therapeutic effect of umbilical cord serum eyedrops for persistent epithelial defect. Korean J Ophthalmol. 2005;19:174-178.